--- title: "Brain Scientific Inc. (BRSF.US)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/BRSF.US.md" symbol: "BRSF.US" name: "Brain Scientific Inc." industry: "Health Care Equipment" --- # Brain Scientific Inc. (BRSF.US) | Item | Detail | |------|--------| | Industry | Health Care Equipment | | Location | US Market | ## Company Profile Brain Scientific Inc., a medtech company, provides neurology and motion products in the United States and internationally. It offers NeuroCap, a disposable soft layered cap with an integrated electrode circuit that is designed to address existing problems of conventional electroencephalography (EEG)... ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-02-20T04:30:12.000Z **Overall: E (0.80)** **Industry**: Health Care Equipment | Metric | Value | |--------|-------| | Industry Ranking | 185 / 185 | | Industry Median | C | | Industry Average | C | - **Style**: Value - Stocks where the company's main business is in a mature stage. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | -19.26% | | | Net Profit YoY | -35.64% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | 0.00 | | | Dividend Ratio | 0.00% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 124.26 | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 214564.00 | | **Multi Score**: E #### Profit Score: E | Indicator | Value | Rating | |-----------|-------|--------| | ROE | -681.55% | E | | Profit Margin | -5753.00% | E | | Gross Margin | 25.32% | C | #### Growth Score: D | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | -19.26% | E | | Net Profit YoY | -35.64% | D | | Total Assets YoY | -12.20% | E | | Net Assets YoY | 721.24% | A | #### Cash Score: D | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | -1.74% | D | | OCF YoY | -19.26% | E | #### Operating Score: E | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 0.02 | E | #### Debt Score: D | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 63.24% | D | ```chart-data:radar { "title": "Longbridge Financial Score - Brain Scientific Inc.", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "E", "indicators": [ { "name": "ROE", "value": "-681.55%", "rating": "E" }, { "name": "Profit Margin", "value": "-5753.00%", "rating": "E" }, { "name": "Gross Margin", "value": "25.32%", "rating": "C" } ] }, { "name": "Growth", "grade": "D", "indicators": [ { "name": "Revenue YoY", "value": "-19.26%", "rating": "E" }, { "name": "Net Profit YoY", "value": "-35.64%", "rating": "D" }, { "name": "Total Assets YoY", "value": "-12.20%", "rating": "E" }, { "name": "Net Assets YoY", "value": "721.24%", "rating": "A" } ] }, { "name": "Cash", "grade": "D", "indicators": [ { "name": "Cash Flow Margin", "value": "-1.74%", "rating": "D" }, { "name": "OCF YoY", "value": "-19.26%", "rating": "E" } ] }, { "name": "Operating", "grade": "E", "indicators": [ { "name": "Turnover", "value": "0.02", "rating": "E" } ] }, { "name": "Security", "grade": "D", "indicators": [ { "name": "Gearing Ratio", "value": "63.24%", "rating": "D" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | Inspire Medical (US.INSP) | A | B | A | A | B | A | | 02 | Delcath (US.DCTH) | C | A | A | A | A | A | | 03 | Intuitive Surgical (US.ISRG) | A | B | C | A | B | B | | 04 | Stryker (US.SYK) | A | B | C | C | B | B | | 05 | Boston Scientific (US.BSX) | B | B | C | C | B | B | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | Dividend Yield | 0.00% | - | - | - | - | ## References - [Company Overview](https://longbridge.com/en/quote/BRSF.US/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/BRSF.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/BRSF.US/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.